Pax-5, a member of the paired domain family of transcription factors, is a key regulator of B lymphocyte-speci®c transcription and differentiation. A major target of Pax-5-mediated activation is the mb-1 gene, which encodes the essential transmembrane signaling protein Ig-a. Pax-5 recruits three members of the Ets family of transcription factors: Ets-1, Fli-1 and GABPa (with GABPb1), to assemble ternary complexes on the mb-1 promoter in vitro. Using the Pax-5:Ets-1:DNA crystal structure as a guide, we de®ned amino acid requirements for transcriptional activation of endogenous mb-1 genes using a novel cell-based assay. Mutations in the b-hairpin/b-turn of the DNA-binding domain of Pax-5 demonstrated its importance for DNA sequence recognition and activation of mb-1 transcription. Mutations of amino acids contacting Ets-1 in the crystal structure reduced or blocked mb-1 promoter activation. One of these mutations, Q22A, resulted in greatly reduced mb-1 gene transcript levels, concurrent with the loss of its ability to recruit Fli-1 to bind the promoter in vitro. In contrast, the mutation had no effect on recruitment of the related Ets protein GABPa (with GABPb1). These data further de®ne requirements for Pax-5 function in vivo and reveal the complexity of interactions required for cooperative partnerships between transcription factors.
INTRODUCTION
Combinatorial association of DNA binding proteins is an important mechanism for regulating the expression of tissuespeci®c genes in differentiated cells. In many cases, cooperative interactions between two or more proteins are important for establishing higher order complexes with increased af®nity for DNA. One example of this can be found in developing B cells, involving proteins from the Pax and Ets families of transcription factors.
Members of the Pax family of transcription factors are important for the control of tissue speci®c transcription during many types of cellular differentiation including brain, eye and lymphoid development (1) , and are also implicated in oncogenesis (2±5). Pax proteins bind DNA via a highly conserved bipartite structure called the paired domain, which consists of a b-hairpin/b-turn and two helix±turn±helix motifs connected by a linker peptide. The paired domain binds DNA sequences comprised of two half-sites separated by one turn of the DNA helix, with each half-site being recognized by one of the two paired domain DNA binding motifs (6) . An inherent exibility of the paired domain enables Pax proteins to bind sequences comprised of very degenerate nucleotide sequences. Therefore, it has been predicted that regulatory mechanisms, including protein±protein interactions, function to enhance the speci®city of Pax family members, including Pax-5.
Ets proteins are a family of transcription factors that control a wide variety of cellular processes including cellular proliferation and differentiation. Ets proteins bind DNA via the ETS domain, a highly conserved winged helix motif shared by all members of the Ets family. Due to the conserved nature of the ETS domain, many family members have very similar patterns of sequence recognition. This creates a potential problem for selective activation of target genes when more than one Ets family member is expressed in a single cell. To compensate for this, the binding speci®city and activity of many Ets family members is regulated through protein±protein interactions with other transcription factors (7±9).
Pax-5 is necessary for B lymphocyte development and is also required for development of the mammalian midbrain segment (10, 11) . Moreover, it has been suggested that Pax-5 mediates the commitment of cells to the B lineage, because B cell progenitors exhibit lineage plasticity in the absence of *To whom correspondence should be addressed. Tel: +1 303 398 1398; Fax: +1 303 398 1396; Email: hagmanj@njc.org . In part, the ability of Pax-5 to promote B cell development is due to its role in activating the expression of B lineage speci®c genes, including mb-1 (Ig-a). We have previously shown that Pax-5 recruits multiple members of the Ets transcription factor family including Fli-1, Ets-1 and GABPa (with GABPb1) to bind a suboptimal Ets binding site (5¢CCGGAG) within the early B-cell speci®c mb-1/Ig-a promoter (between ±86 and ±64) in vitro (13±16). Several lines of evidence suggest that Pax-5 and Ets proteins must work together to activate the promoter. First, binding of these proteins (Pax-5 and Ets-1) to DNA is highly cooperative (D.Fitzsimmons, in preparation). The absence of either partner results in greatly reduced or undetectable DNA binding, suggesting that ternary complex assembly is necessary for stable binding of these proteins to the mb-1 promoter. Second, in vivo footprinting of the mb-1 promoter detected coordinate occupation of Pax-5 and Ets binding sites in early B cells (17) . Third, mutation of either the Ets or Pax-5 binding site in reporter assays similarly decreased mb-1 promoter activity in B cells (13) . Finally, the requirement of both components for transcriptional activation is strongly implied by studies of endogenous mb-1 gene activation in retrovirally transduced plasmacytoma cells (16) . In this system, transcriptional activation by Pax-5 is dependent on an unmethylated Ets binding site. Methylation of this site blocks binding of Ets proteins in vitro, prevents ternary complex formation and inhibits transcriptional activation in reporter assays.
The interaction between Pax-5 and Ets proteins occurs solely between each protein's DNA binding domain. The crystal structure of the ternary complex of the paired DNA binding domain of Pax-5 and the ETS domain of Ets-1 bound to mb-1 promoter DNA was solved recently (18) . The paired domain of Pax-5 is comprised of two domainsÐthe N-terminal domain (NTD) and the C-terminal domain (CTD)Ðwhich are connected by a short linker. Both the NTD and CTD are comprised of three a-helices and make sequence-speci®c contacts to DNA through a helix±turn±helix motif. The NTD also contains a b-hairpin at its N-terminus that appears to make a number of contacts to the sugarphosphate backbone of DNA. The crystal structure revealed that residues in the b-hairpin and one of the a-helices in the NTD are responsible for cooperative interactions between Pax-5 and select Ets family members.
In order to determine the relative importance of residues within the b-hairpin of the NTD of Pax-5 in a relatively physiological setting, we used a novel cell-based system to analyze the effects of point mutations on the activation of endogenous mb-1/Ig-a transcription and recruitment of endogenous Ets proteins. Our results suggest that the b-hairpin plays an essential role in stabilizing Pax-5 on the mb-1 promoter, enabling transcriptional activation. In contrast, mutations within the b-hairpin did not cause a reduction in DNA binding to a different Pax-5-DNA binding site, highlighting the differential utilization of motifs within Pax-5 for binding to distinct nucleotide sequences. Mutation of amino acids predicted to participate in protein±protein interactions resulted in drastic differences in the ability of Pax-5 to recruit Ets partners. One of these mutations revealed that Pax-5 differentially recruits two Ets family members, Fli-1 and GABPa (with GABPb1). These data lead us to conclude that the b-hairpin of Pax-5 is essential for mb-1 promoter transcriptional activity and that Pax-5 likely utilizes different amino acid residues to recruit different members of the Ets family to bind DNA. These differences may lead to the preferential recruitment of one Ets protein over another in vivo, leading to optimal transcriptional activity.
MATERIALS AND METHODS
Cell lines and cell culture mM.10 cells, a clone of the J558LmM cell line (16) were cultured in RPMI 1640 medium containing 10% FBS (Gemini Bioproducts, Woodland, CA), 2 mM L-glutamine, 50 mg/ml gentamicin, 1Q HT Media Supplement (Sigma, St Louis, MO), 0.3 mg/ml xanthine (Sigma) and 1 mg/ml mycophenolic acid (Sigma). The pre-B cell line 40E1 was cultured in Iscove's Modi®ed Dulbecco's Medium (IMDM; Cellgro, Herndon, VA) containing 10% FBS (Gemini), 2 mM L-glutamine (Invitrogen, Carlsbad, CA), 50 mg/ml gentamicin (Invitrogen), and 50 mM b-mercaptoethanol (Sigma). The FNX retroviral packaging line was kindly provided by Phillipa Marrack (19) and cultured in IMDM containing 10% FBS, 2 mM L-glutamine and 50 mg/ml gentamicin. All cell lines were grown at 37°C and 6% CO 2 .
Plasmid constructs
Retroviral vectors for expression of mutated Pax-5 proteins were prepared as follows. Plasmid pPax-5-AgeWT was prepared by mutagenesis of the coding region of Pax-5 to include an AgeI restriction site at codons 149±151, which changes the nucleotide sequence to CAACCGGTC without changing the encoded amino acid sequence. PCR mutagenesis (15) was performed using the plasmid Pax-5.S1 (13) as template and primer pairs 5¢CTCTTAACCGGTCCCAG-CTTCCAGTCACAGCAT and 5¢AGGAAGTCTCTGCCCG-GAAGC. The ampli®ed fragment was ligated into Pax-5.S1 cut with BspE1 and Ecl136II, and ®lled in with Klenow. To produce full length Pax-5 with paired domain mutations, the resulting plasmid was cut again with Ecl136II and AgeI, ®lled in with Klenow, and ligated with fragments ampli®ed from previously mutated Pax-5 sequences (15) using primers 5¢CTCATCATGGATTTAGAGAAAAATTATCC and 5¢TTG-GTTGGGTGGCTGCTGTACT. To generate retroviral vectors, mutated Pax-5 sequences were excised with Ecl136II and SalI, ®lled in with Klenow and ligated into the XhoI site of the MSCV2.2-IRES-GFPa retroviral vector provided by Dr P. Marrack (20) . All plasmids were con®rmed by DNA sequencing. The plasmid pCL-Eco (21) was a kind gift from Dr I. Verma.
Retrovirus production and transduction
Retrovirus production and transduction of mM.10 cells were performed as previously described (16) . Transduced cells were analyzed for surface mIgM expression on day 3 posttransduction. Cells were also sorted for GFP expression using identical gates based on GFP expression and collected for further analysis (RNA and protein).
Flow cytometry and western blotting
For¯ow cytometry, biotin-conjugated anti-IgM was purchased from Caltag Laboratories (Burlingame, CA).
Streptavidin-conjugated allophycocyanin (APC) was purchased from BD Pharmingen (San Diego, CA). Dead cells were excluded by staining with propidium iodide. Flow cytometry was performed on a FACScaliburÔ machine (Becton Dickinson, San Diego, CA). For western blotting, rabbit anti-human Pax-5 antibody was purchased from Geneka (Montreal, Canada). HRP-conjugated F(ab)¢ 2 donkey antirabbit IgG was purchased from Amersham Biosciences Corp. (Piscataway, NJ). Whole cell lysates of equivalent cell numbers were lysed in 2Q Laemmli Buffer (Bio-Rad, Hercules, CA). Equivalent amounts of whole cell lysates or nuclear extracts (12 mg) were separated on 10% SDS± PAGE gels. Western blotting was performed as previously described (16) .
Preparation of RNA and real-time RT±PCR
Recovery of RNA from transduced cells and real-time RT± PCR analysis of b-actin and mb-1 transcripts was performed as previously described (16) .
Recombinant proteins and electrophoretic mobility shift assays (EMSA)
Recombinant Pax-5 (1±149) was described previously (15) . Recombinant Ets-1 (331±440) and GABPa/b1 complex was kindly provided by Dr Cynthia Wolberger (Johns Hopkins University). The plasmid for in vitro translation of the Fli-1 ETS domain was described previously (13) . Annealing, labeling of DNA probes and electrophoretic mobility shift assays were performed as previously described (14) . Probe sequences were as follows: mb-1: 5¢TCGAAGGGCCACTG-GAGCCCATCTCCGGCACGGC and 5¢TCGAGCCGTGC-CGGAGATGGGCTCCAGTGGCCCT; Ie: 5¢TCGAGCTGA-GGGCACTGAGGCAGAGCGGCCCCTA and 5¢TCGATA-GGGGCCGCTCTGCCTCAGTGCCCTCAGC; M17 promoter Sp1 binding site: 5¢TCGAGGCACCTCCTCTTTCTG-ACT and 5¢TCGAGTCAGAAAGAGGAGGTGCCT. Nuclear extracts were prepared as previously described (16), except Buffer A contained 10 mM HEPES (pH 7.9), 10 mM KCl, 1.5 mM MgCl 2 , 1 mM DTT plus protease inhibitors (1.5 mM PMSF, 10 mg/ml leupeptin, 10 mg/ml aprotinin) and Buffer C contained 20 mM HEPES (pH 7.9), 0.4 M NaCl, 1.5 mM MgCl 2 , 1 mM DTT, 0.5% NP40 plus protease inhibitors. For supershifting, anti-Ets-2 and anti-Fli-1 antisera was purchased from Santa Cruz Biotechnologies, Inc. (Santa Cruz, CA). Anti-GABPb1 antisera was provided by Tom Brown (P®zer Central Research, Groton, CT). Anti-Pax-5 antisera is described above.
RESULTS

Transcriptional activation of endogenous mb-1/Ig-a genes by Pax-5 mutants
To assess the relative contribution of amino acids in the NTD of Pax-5 to the formation of Pax-5:Ets:DNA ternary complexes, we made use of a recently developed cell-based system to analyze the ability of Pax-5 mutant proteins to recruit endogenous Ets partner proteins and activate endogenous mb-1/Ig-a genes (16) . Brie¯y, mM.10 is a plasmacytoma cell line expressing three of the four B-cell receptor (BCR) components necessary for display of IgM on the plasma membrane (mIgM) of B cells: m Ig heavy chain, l Ig light chain and B29/Ig-b. In the absence of the fourth component, mb-1/Ig-a, mIgM remains in the cytoplasm. Importantly, mM.10 cells do not express endogenous Pax-5. Upon induction of mb-1/Ig-a transcription by retrovirally expressed Pax-5 proteins, expression of mIgM can be detected on the cell surface by¯ow cytometry, providing an indirect measure of mb-1/Ig-a transcriptional activation in individual cells. To express wild-type and mutant Pax-5 proteins, we generated recombinant mouse stem cell viruses (MSCV) that transcriptionally link expression of enhanced green¯uorescent protein (GFP) to expression of Pax-5 via an internal ribosomal entry sequence [IRES; (20) ]. Therefore,¯ow cytometry enables levels of mIgM expression to be analyzed with respect to the relative expression of Pax-5 as indicated by GFP¯uorescent intensity. Moreover, expression of GFP allows for cell sorting and recovery of relatively homogeneous populations of transduced cells for biochemical analysis.
mM.10 cells were transduced with retroviruses encoding control (cGFP), or full length wild-type or mutated Pax-5 proteins, then analyzed for mIgM expression by¯ow cytometry ( Fig. 2A) . GFP+ cells were also sorted for analysis of mb-1 transcripts using real time PCR (Fig. 2B) , and western blot analysis of Pax-5 expression, which con®rmed similar expression of Pax-5 proteins in all transduced cell populations (Fig. 2C) . While the cGFP-expressing cells did not express mIgM, transduction with wild-type Pax-5 retroviruses induced mIgM expression on 45.7 T 0.64% of GFP+ cells. Gly19 is ordered in the crystal structure and forms part of the b-hairpin (Fig. 1) . We predicted that mutation to alanine would have no effect on the hydrogen bonds it can make or in the f±y conformation it can adopt. Indeed, mutation of Gly19 to arginine (G19R) did not affect mIgM expression (46.1 T 0.59%) or mb-1 transcript levels. Asn21 is important both for folding of the b-hairpin/b-turn structure and for DNA binding. Asn21 contacts the mainchain oxygen of Arg59 between helices 2 and 3 of the amino-terminal subdomain (NTD) and hydrogen bonds to two phosphates of the DNA backbone (Fig. 1) . Mutation of Asn21 to alanine (N21A) completely abolished the ability of Pax-5 to activate mb-1/Ig-a transcription, suggesting that the b-hairpin/b-turn motif is indeed required for DNA binding in cells. A similar loss of function was observed with mutation of Leu23 to alanine or glycine. Leu23 mediates intermolecular contacts with Ets-1 via van der Waals interactions with Lys399 of Ets-1, which assembles an intramolecular salt bridge with Asp398. Leu23 also makes two other potential contacts within Pax-5: a van der Waals contact with Val60, and a weak interaction with Arg59 (Fig. 1) . Pax-5 L23A produced some IgM+ cells (1.3 T 0.11%), while L23G resulted in no IgM+ cells. A compound mutation with both Q22A and L23A produced the same phenotype as L23A alone. These data suggest that Leu23 does indeed have an important role for the structure and/or function of the b-hairpin/b-turn. A complete lack of activation was observed with mutations F27A or G30S, which are predicted to disrupt the b-hairpin and b-turn, respectively. The phenyl ring of Phe27 anchors the antiparallel b-sheet structure of the b-hairpin through stacking interactions with a ribose group of the DNA. Gly30 makes contacts with the minor groove of DNA, facilitates formation of the b-turn, and is equivalent to an amino acid in Pax-1 that is mutated in the undulated mouse (22) When the three amino acids suspected of participating in recruitment of Ets partners (Gln22, Leu23 and Arg56) were mutated, only Q22A maintained the ability to activate mb-1 transcription, albeit at signi®cantly reduced levels ( Fig. 2A  and B ). Gln22 has been previously identi®ed as playing a key role in Pax-5:Ets interactions (14) . Gln22 forms hydrogen bonds with Gln336 and Tyr395 of Ets-1 (Fig. 1) . These interactions stabilize changes in the conformation of Tyr395 of Ets-1, which rotates approximately 90°in order for Ets-1 to bind stably to the suboptimal binding site of the mb-1 promoter. Gln22 also contacts the phosphodiester backbone. We previously showed that mutation of Pax-5 Gln22 to alanine reduces recruitment of Ets-1 by 75±80% in vitro, but has little or no effect on binding of Pax-5 by itself to various sites (14) . Here, we show that the Q22A mutation signi®cantly reduces the ability of Pax-5 to activate transcription of endogenous mb-1 genes. In the mM.10 system, Pax-5 Q22A activates mIgM expression in only 29.6 T 2.1% of GFP+ cells ( Fig. 2A) , a 35.2% reduction compared to wild-type. In addition, the mean¯uorescence intensity (MFI) of the mIgM+ population is reduced compared to that of wild-type Pax-5 (34.1 T 1.4% versus 53.8 T 1.2%). Real-time PCR analysis revealed that the transcriptional effect of this mutation is a 64% reduction in mb-1 transcripts (Fig. 2B) , re¯ecting both the reduced number of mIgM+ cells and the lower MFI.
DNA binding by Pax-5 mutants
To determine whether the phenotypes observed in transduced mM.10 cells were due to inhibition of DNA binding or an inability to recruit Ets partners, nuclear extracts were prepared from transduced cells sorted for equivalent levels of GFP expression and expanded in culture for 1 week prior to preparation of nuclear extracts. Figure 3A shows binding by proteins in the nuclear extracts to two Pax-5 binding sites: the mb-1 ternary complex site and the high af®nity binding site of the Ig heavy chain locus Ie promoter (23) . As expected, both wild-type Pax-5 and Pax-5 G19R bound equivalently to the mb-1 probe and recruited Ets partners to assemble ternary complexes. Mutations in residues predicted to make contacts with the DNA backbone, including N21A, F27A and G30S, all greatly decreased Pax-5 binding to the mb-1 probe, corresponding with the lack of detectable mb-1 transcripts. Ternary complexes were likewise reduced. Mutations in Leu23 and Arg56 are predicted to disrupt contacts with Ets partner proteins, but also affect intramolecular interactions (made by Leu23; see previous section) or contacts with DNA (Arg56). These properties result in the mutants' signi®cantly decreased abilities to bind the mb-1 probe, in addition to reduced ternary complex assembly. Interestingly, the ability of these mutated Pax-5 proteins to bind the Ie probe was not greatly affected, suggesting different amino acid requirements for recognition of this site. Surprisingly, the Q22A mutation eliminated the faster migrating ternary complexes, while slower migrating ternary complexes were enhanced slightly (by 2-fold). The residual ability of Pax-5 Q22A to activate mb-1/Ig-a transcription is likely due to activities of the slow migrating complexes. Identi®cation of proteins within these ternary complexes is discussed below. 
Identi®cation of Ets proteins in mM.10 ternary complexes
Nuclear proteins from cells transduced with wild-type Pax-5 retroviruses assembled distinct ternary complexes when incubated with the mb-1 promoter probe. When transduced with Pax-5 Q22A, the faster migrating ternary complexes disappeared, while slower migrating complexes were slightly increased. To identify components of these complexes, a supershifting experiment was performed using antibodies against Pax-5, the Ets proteins Fli-1 and Ets-2, and the partner of GABPa, GABPb1 (supershifting antibodies recognizing GABPa are not available). The experiment revealed that Pax-5 and Fli-1 are present together in the faster migrating complexes (Fig. 4) . In support of the detection of Fli-1 together with Pax-5, we previously detected these complexes in supershifting assays using extracts of cell lines representing pre-B and immature B cells (13) . Fli-1 contains homologs of each of the amino acids contacted in Ets-1 by Pax-5, thus the Q22A mutation that inhibits Ets-1 binding by Pax-5 should have similar effects on recruiting Fli-1. Reactivity with antiGABPb1 antiserum shows that the slower migrating complexes include Pax-5 and GABPa/b1. Previous analysis with anti-Ets-1 antiserum suggested that the slower migrating complexes include Ets-1 (16) . However, this antiserum crossreacts with GABPa, and Ets-1 is undetectable in mM.10 cells by western blotting (H.Maier, data not shown). Together with previous data, these results suggest that the Q22A mutation has a profound effect on recruitment of some (Ets-1 and Fli-1) but not all Ets proteins recruited to the mb-1 promoter by Pax-5.
Differential recruitment of recombinant Fli-1 and Ets-1 versus GABPa/b by Pax-5 in vitro
We previously showed that Ets proteins including Fli-1, Ets-1 and GABPa are recruited by Pax-5 to bind the mb-1 promoter in vitro. The molecular basis for this recruitment includes a network of amino acids that are largely shared between these proteins. However, our data suggest differential requirements for Gln22 of Pax-5 for recruitment of Fli-1 versus the GABPa/ b1 complex. To further address this issue, we performed EMSA to test the relative abilities of recombinant wild-type Pax-5 or Pax-5 Q22A paired domains to recruit ETS domains of Fli-1, Ets-1, or GABPa in vitro. The ETS domain of GABPa was tested together with an amino terminal fragment of GABPb1 (24) . These proteins were previously shown to associate stably with each other in the absence of DNA, and the b subunit is necessary for high af®nity DNA binding to DNA by the GABPa/b complex in vitro (25±27). DNA binding by Pax-5 wild-type and Q22A proteins, which bind the promoter with similar af®nities (D.Fitzsimmons, manuscript in preparation), was adjusted to similar levels. Addition of recombinant ETS domains each resulted in the detection of similar levels of ternary complexes with wild-type Pax-5 (Fig. 5) . In contrast, the Q22A mutation greatly reduced levels of ternary complexes including ETS domains of Fli-1 (2.5% of wild-type) or Ets-1 (7.7% of wild-type), but had only a very small effect on recruitment of GABPa/b1 (71% of wild type). We conclude that differences in the recruitment of Ets proteins by Pax-5 are intrinsic to their respective DNA-binding domains. Moreover, the difference between recruitment of Fli-1 and Ets-1 versus GABPa/b de®nes an additional level of complexity in interactions between Pax-5 and its Ets partners.
DISCUSSION
Protein±protein interactions between transcription factors are an important mechanism for transcriptional regulation of Figure 4 . Identi®cation of Ets proteins in ternary complexes. mb-1 probe mobility shift assays using nuclear extracts from wild-type Pax-5-transduced mM.10 plasmacytoma cells (16) were performed as in Figure 3 with the inclusion of antisera speci®c for Pax-5, Fli-1, Ets-2 or the GABPa partner, GABPb, as indicated. The asterisk indicates degraded Pax-5 protein. tissue and developmental stage-speci®c genes. We have previously shown that one such interaction, between the paired domain of Pax-5 and Ets family members, is important for transcriptional activation of the early B-cell speci®c mb-1/ Ig-a promoter (13, 14) . However, previous studies relied on transient transfection assays to determine the relative importance of the Pax-5 and Ets binding sites and the use of in vitro binding assays to de®ne important amino acids leading to ternary complex formation. The development of a novel cellbased system to analyze endogenous gene expression in the context of chromatin (16) allowed us to assay structural requirements for Pax-5 DNA binding and interactions with Ets proteins in a more physiological manner. The crystal structure of the Pax-5:Ets-1:DNA ternary complex was used as a guide to select residues that are involved in DNA-binding and/or interaction with Ets partner proteins. Mutated full-length Pax-5 proteins were retrovirally expressed in a specialized plasmacytoma cell line that allows us to assess transcriptional activation of endogenous mb-1/Ig-a genes via¯ow cytometry. This system provides an additional advantage in that it relies on recruitment of endogenously expressed Ets partner proteins by Pax-5. Therefore, this system allows for the physiological analysis of the importance of Pax-5 amino acid contributions to DNA binding and recruitment of Ets proteins and the activation of mb-1/Ig-a transcription.
Previous studies have revealed differential requirements for the NTD and CTD of the paired domain of Pax-5 at different binding sites (6, 14, 15, 28) . For example, in the absence of the CTD, Pax-5 is still able to bind certain nucleotide sequences, such as the site identi®ed within the Ig heavy chain switch region g2a promoter. Both NTD and CTD regions are required for binding sites within the CD19, Ie and mb-1 promoters, but amino acid sequence requirements are different for each of these sites. For example, Gly30 is essential for binding the mb-1 and CD19 promoters, but not the Ie site. Amino acids of the b-hairpin, including Asn21 and Phe27, are required for binding mb-1, but not the CD19 or Ie sites. Together, these data suggest differential utilization of motifs within the paired domain, and of individual amino acids, for DNA recognition.
Amino acids of the b-hairpin/b-turn motif are highly conserved among members of the Pax family in humans, mice and more distantly related organisms including Caenorhabditis elegans and jelly®sh (15) . Interestingly, mutations in Pax proteins resulting in disease often reside within this motif (22, 29, 30) . Our previous studies de®ned the importance of the paired domain b-hairpin/b-turn for Pax-5 DNA binding and Pax-5:Ets ternary complex formation in vitro (14,15), but we were unable to assess effects of these mutations on Pax-5 function in a more physiological context. In the present study, we con®rmed previous results and showed that many mutations in the b-hairpin/b-turn reduce Pax-5 binding to the mb-1 promoter and prevent activation of mb-1 transcription, but do not signi®cantly affect binding to the Ie Pax-5 binding site. Thus, the b-hairpin/b-turn is an essential motif required for paired domain function in B cells, and likely, other cell types.
Gln22 of Pax-5 was previously identi®ed as being particularly important for interactions with Ets-1, since mutation of Gln22 to an alanine resulted in a 75±80% reduction in Ets-1 recruitment in in vitro binding assays (14) . When introduced into the mM.10 cell system, Pax-5 Q22A resulted in a 64% reduction in mb-1 transcript levels. Surprisingly, in vitro DNA binding analysis of nuclear extracts from sorted Pax-5 Q22A-expressing cells revealed that formation of only one of two types of Pax-5:Ets ternary complexes was inhibited by the Q22A mutation (Fig. 3A) . Further examination revealed that complexes reduced by the Q22A mutation contain Fli-1, while the unaffected complexes contain GABPa/GABPb1 (Fig. 4) . These data are only partially explained by our previous structural studies of complexes containing Pax-5 and Ets-1. Fli-1 includes residues corresponding to Gln336, Tyr395, Glu398 and Lys399 of Ets-1. Therefore, we expect Fli-1 to assemble nearly identical networks of protein±protein contacts with Pax-5. In contrast, at the position of Lys399 in Ets-1, GABPa contains a glycine, which may indirectly impair assembly of the intermolecular salt bridge with Arg56 of Pax-5. In addition, although GABPa includes a glutamine similar to Gln336 of Ets-1, this amino acid is complexed with the GABPb1 protein (24) , and therefore may not be available for interaction with Pax-5.
The question arises as to the identity of the Ets protein(s) that regulate mb-1 transcription together with Pax-5 in vivo. Previous studies showed that Pax-5 assembles ternary complexes in vitro with Fli-1, Ets-1 and GABPa/b in pre-B cell nuclear extracts (13) . However, in this study, evidence was obtained for activation of the mb-1 promoter by Pax-5 with Fli-1, GABPa/b, or both Ets proteins in mM.10 cells (which do not express detectable Ets-1; H.Maier, data not shown). Unfortunately, it is not technically feasible at this time to de®nitively determine which of the three potential Ets partners functions together with Pax-5 in vivo. This is due both to the lack of highly speci®c antibody reagents suitable for chromatin immunoprecipitation (ChIP) of Ets proteins, and to the presence of an additional Ets binding site immediately downstream of the Pax-5:Ets ternary complex binding site in the mb-1 promoter. In EMSA assays with nuclear extracts or recombinant Ets proteins, binding to the second site is independent of Pax-5 binding in vitro. Thus, although ChIP assays may be able to determine whether an Ets protein(s) binds the promoter in vivo, they would be unable to determine which of the two adjacent sites is bound by the immunoprecipitated protein. Our studies suggest that Pax-5 may be able Figure 5 . Ternary complex assembly by Pax-5 wild-type or Q22A paired domains with ETS domains of Fli-1, Ets-1, or GABPa/b1. EMSA was performed as previously described (13) using recombinant wild-type or Q22A Pax-5 (1±149) proteins, alone or together with ETS domains of Fli-1 (residues 279±366), Ets-1 (residues 331±440), or GABPa (residues 320± 429). Recombinant GABPa ETS domain was added in equimolar concentrations with GABPb1 (5±157). After non-denaturing polyacrylamide gel electrophoresis, DNA binding was quanti®ed using a Molecular Dynamics Typhoon PhosphorImager system. to activate transcription with more than one kind of Ets protein. This is not entirely surprising in light of previous data showing that the ability to interact with Pax proteins is a highly conserved property of Ets proteins from species as distantly related as humans and C.elegans (15) . Further studies are necessary to understand how Pax-5 and different Ets proteins assemble ternary complexes, and how well the various complexes are able to activate transcription of the mb-1 promoter. In conclusion, the difference in the molecular mechanisms for recruitment of Ets-1 and Fli-1 versus GABPa/ b1 by Pax-5 increases the complexity of how Pax-5 assembles complexes with Ets proteins, a paradigm for partnerships between factors that are members of extensive families of proteins with similar properties.
